다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
XTL Biopharmaceuticals Ltd (XTLB)
XTL Biopharmaceuticals Ltd (XTLB) 뉴스

XTLB

XTL Biopharmaceuticals (XTLB)

XTL Biopharmaceuticals Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:XTLB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/13	23:32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/03/20	23:15	GlobeNewswire Inc.	XTL To Aquire The Social Proxy	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/11/16	00:29	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/10/21	05:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/10/21	05:00	GlobeNewswire Inc.	XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/10/21	05:00	GlobeNewswire Inc.	XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/08/10	22:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/05/17	00:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/02/24	04:30	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/02/01	23:53	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/08/24	23:31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/03/31	06:16	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/01/27	02:43	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/01/20	01:04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/12/17	07:17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/11/25	00:39	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/06/08	19:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/05/20	00:40	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/05/20	00:31	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/05/20	00:26	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/01/07	23:10	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/01/01	01:12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/11/26	00:43	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/11/13	00:00	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/08/24	22:24	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/07/07	21:04	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/06/30	20:52	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/05/27	22:21	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/05/26	22:46	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2020/05/26	19:18	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd

검색 관련기사 보기:NASDAQ:XTLB

1 2 3 4 5 6 7 8 9 10 다음 >>

Intesa Sanpaolo

Ssga Spdr S&p Us Dividen...

GZ6GTechnologies (CE)

ICONIC XBTI INAV IXBTI

Colu Local Network

MacaronSwap Token

Exchange Traded Fund Ubs...

Badlands Resources (QB)

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관